The goal of disease-directed treatment is to diminish or down-regulate the auto-immune reaction of activated T-lymphocytes against myelin antigens.
Sponsored by:
THE EUROPEAN COMMISSION
DG INFORMATION SOCIETY
UNIT B1-APPLICATION RELATING TO HEALTH
Top | Go to the main menu | Go to the secondary menu
